Trial · NCT00991029
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Composite of Ischemic Stroke, Myocardial Infarction, or Death From Ischemic Vascular Causes | Up to 90 days | Primary efficacy outcome: Number of Participants with Ischemic Stroke, Myocardial Infarction, or Death From Ischemic Vascular Causes |
| Primary | Major Hemorrhage | Up to 90 days | Primary safety outcome: Number of Participants with major hemorrhage |
| Secondary | Ischemic Stroke | Up to 90 days | Secondary efficacy outcome:Number of participants with Ischemic stroke |
| Secondary | Myocardial Infarction | Up to 90 days | Secondary efficacy outcome: Number of participants with Myocardial infarction |
| Secondary | Death From Ischemic Vascular Causes | Up to 90 days | Secondary efficacy outcome: Number of participants with Death from ischemic vascular causes |
| Secondary | Ischemic or Hemorrhagic Stroke | Up to 90 days | Secondary efficacy outcome: Number of participants with Ischemic or hemorrhagic stroke |
| Secondary | Composite of Ischemic Stroke, Myocardial Infarction, Death From Ischemic Vascular Causes, or Major Hemorrhage | Up to 90 days | Secondary efficacy outcome: Number of participants with ischemic stroke, myocardial infarction, death from ischemic vascular causes, or major hemorrhage |
| Other | Hemorrhagic Stroke | up to 90 days | Other safety outcome: Number of participants with Hemorrhagic stroke |
| Other | Symptomatic Intracerebral Hemorrhage | up to 90 days | Other safety outcome: Number of participants with Symptomatic intracerebral hemorrhage |
| Other | Other Symptomatic Intracranial Hemorrhage | up to 90 days | Other safety outcome: Number of participants with other symptomatic intracranial hemorrhage |
| Other | Major Hemorrhage Other Than Intracranial Hemorrhage | up to 90 days | Other safety outcome: Number of Participants with Major hemorrhage other than intracranial hemorrhage |
| Other | Minor Hemorrhage | up to 90 days | Other safety outcome:Number of Participants with Minor hemorrhage |
| Other | Death From Any Cause | up to 90 days | Other safety outcome: Number of Participants with Death from any cause |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00991029/registered